Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Lumbar Spine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    279 result(s) found for: Lumbar Spine. Displaying page 1 of 14.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2015-003539-37 Sponsor Protocol Number: CZOL446H2202 Start Date*: 2016-03-07
    Sponsor Name:Novartis
    Full Title: An international, multicenter, randomized, open-label, parallel efficacy, and safety trial of intravenous zoledronic acid compared to intravenous pamidronate in children with severe osteogenesis im...
    Medical condition: Osteogenesis Imperfecta
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2016-002887-14 Sponsor Protocol Number: 2.0 Start Date*: 2016-10-31
    Sponsor Name:University of Turku
    Full Title: Dose response study of Patient Controlled Analgesia (PCA) of S-ketamine in orthopaedic spine surgery patients
    Medical condition: Patients who are scheduled for elective posterolateral lumbar spine fusion with bilateral transpedicular screw instrumentation
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004859 10041595 Spinal stenosis lumbar LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2014-003252-31 Sponsor Protocol Number: 2.0 Start Date*: 2015-05-15
    Sponsor Name:University of Turku
    Full Title: Dose response study of Patient Controlled Analgesia (PCA) of Dexmedetomidine in orthopaedic spine surgery patients
    Medical condition: Patients, who are scheduled for elective posterolateral lumbar spine fusion with bilateral transpedicular screw instrumentation
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004859 10041595 Spinal stenosis lumbar LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003564-57 Sponsor Protocol Number: Adalimumab1- 2006 Start Date*: 2006-11-02
    Sponsor Name:Kuopio University Hospital
    Full Title: Adalimumab (anti TNF alfa) in the management of acute lumbar disc prolapses -a one year, randomized, placebo controlled, double blind, single center trial
    Medical condition: Patients with acute or subacute (no more than 2 months) clinical sciatica caused by herniated disc prolapse
    Disease: Version SOC Term Classification Code Term Level
    8.1 10036852 Prolapsed lumbar disc LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017765-31 Sponsor Protocol Number: LIASELKÄ001 Start Date*: 2010-02-17
    Sponsor Name:Mikko Pitkänen
    Full Title: Local infiltration analgesia for pain relief after lumbar fusion surgery
    Medical condition:
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-011920-69 Sponsor Protocol Number: 0822-043-00 Start Date*: 2011-08-05
    Sponsor Name:Merck & Co., Inc.
    Full Title: A Quantitative Computed Tomography (QCT) Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fra...
    Medical condition: postmenopausal osteoporosis
    Disease:
    Population Age: Elderly Gender: Female
    Trial protocol: NO (Completed)
    Trial results: View results
    EudraCT Number: 2020-000135-47 Sponsor Protocol Number: 21/103 Start Date*: 2021-11-02
    Sponsor Name:Hospital Universitario Fundación Alcorcón
    Full Title: Analgesic efficacy of erector spinae plane block in lumbar spine surgery: a prospective, randomized and double blind study.
    Medical condition: The analgesic efficacy of erector spinae plane block in lumbar spine surgery. Infiltration of local anesthetic in this plane may lower postoperative pain.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-000485-13 Sponsor Protocol Number: 2003100 - HMR4003I/3001 Start Date*: 2006-03-28
    Sponsor Name:Procter & Gamble Ltd
    Full Title: A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of One-year Duration Followed by 2 Years of Open-label Treatment to Determine the Safety and Efficacy of Orally Adm...
    Medical condition: Osteogenesis Imperfecta
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed) BE (Completed) ES (Completed) HU (Completed) CZ (Completed) DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-024393-19 Sponsor Protocol Number: 20101217 Start Date*: 2012-04-16
    Sponsor Name:Amgen, Inc.
    Full Title: A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals
    Medical condition: Glucocorticoid-induced osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004859 10031287 Osteoporosis steroid-induced LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) HU (Completed) NL (Completed) CZ (Completed) ES (Completed) PL (Completed) DE (Completed) DK (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2019-003590-25 Sponsor Protocol Number: NL Start Date*: 2020-06-15
    Sponsor Name:
    Full Title: a Randomized controlled trial for epidural Analgesia for Pain relief after lumbar Interlaminar Decompressive spine surgery - RAPID
    Medical condition: Lumbar spinal stenosis
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004859 10041595 Spinal stenosis lumbar LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-004504-31 Sponsor Protocol Number: 0822-031 Start Date*: 2008-09-16
    Sponsor Name:Merck Sharp & DOhme (Sweden) AB
    Full Title: A Phase III Randomized, Placebo-Controlled Study to Evaluate the Effect of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Overall Safety, and to Estimate the Effect of Odanacatib (MK-0822) ...
    Medical condition: low BMD (bone mineral density)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10032364 Other osteoporosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Prematurely Ended) FR (Completed) DK (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-000747-26 Sponsor Protocol Number: KETTO201200047426 Start Date*: 2012-04-27
    Sponsor Name:Helsinki Universiy Central Hospital
    Full Title: Administration of S-Ketamine during spinal surgery to reduce postoperative pain
    Medical condition: adult patients undergoing spinal surgery
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10041595 Spinal stenosis lumbar LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000638-35 Sponsor Protocol Number: CZOL446N2312 Start Date*: 2004-09-15
    Sponsor Name:Novartis Sverige AB
    Full Title: A 2-year randomized, multicenter, double-blind, placebocontrolled study to determine the efficacy and safety of intravenous zoledronic acid 5 mg administered either annually at randomization and 12...
    Medical condition: Postmenopausal Osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-001666-40 Sponsor Protocol Number: CZOL446H2202E1 Start Date*: 2005-02-01
    Sponsor Name:Novartis Pharma AG
    Full Title: An international, multicenter, randomized, open-label, safety and efficacy trial of intravenous zoledronic acid administered either once or twice yearly in children with severe osteogenesis imperfe...
    Medical condition: Osteogenesis Imperfecta
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: HU (Prematurely Ended) GB (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2011-006152-36 Sponsor Protocol Number: 1774 Start Date*: 2012-05-10
    Sponsor Name:Middelfart Rygsektor
    Full Title: Postoperative treatment with parathyroidea hormone Forteo® in patients undergoing posterolateral spinal fusion surgery. A prospektive and a randomized double-blinded, placebo-controlled study
    Medical condition: Spinal stenosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10028395 - Musculoskeletal and connective tissue disorders 10041597 Spinal stenosis of lumbar region LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-006315-68 Sponsor Protocol Number: B3D-EW-GHDH Start Date*: 2007-05-07
    Sponsor Name:Eli Lilly and Company Limited
    Full Title: Comparison of the Effects of Teriparatide with those of Risendronate on Lumbar Spine Volumetric Bone Mineral Density in GLucocorticpid-Induced Osteoporosis in Men
    Medical condition: Males with glucocorticoid-induced osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed) GR (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-001521-98 Sponsor Protocol Number: 2007008 Start Date*: 2007-11-13
    Sponsor Name:Procter & Gamble Pharmaceuticals
    Full Title: A Non-inferiority Comparison of 35mg Delayed-release Risedronate, Administered Once-weekly Either Before or After Breakfast, and 5mg Immediate-release Risedronate, Administered Once-daily Before Br...
    Medical condition: Treatment of Post-menopuasal Osteoporosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10031285 Osteoporosis postmenopausal LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: EE (Completed) HU (Completed) BE (Completed) FR (Completed) PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017649-67 Sponsor Protocol Number: nnisbjl2009 Start Date*: 2010-06-22
    Sponsor Name:The Central Remedial Clinic and The Children's University Hospital
    Full Title: Bone Health in Duchenne Muscular Dystrophy- a case controlled study of Risedronate use
    Medical condition: Bone Health in Duchenne Muscular Dystrophy- a randomised controlled study of Risedronate use
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male
    Trial protocol: IE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023262-46 Sponsor Protocol Number: 20101005PH Start Date*: 2011-03-08
    Sponsor Name:Royal Devon & exeter Foundation trust
    Full Title: A Randomised Prospective Pilot Study Comparing the Outcomes of Patients with Lumbar Nerve Root Pain Secondary to Lumbar Disc Prolapse Treated by Nerve Root Block with or without the Addition of Clo...
    Medical condition: Lumbar nerve root pain secondary to disc prolapse.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-000861-12 Sponsor Protocol Number: CZOL446H2409 Start Date*: 2007-01-29
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A one-year partial double-blinded, randomized, multi-center, multi-national study to assess the effects of combination therapy of annual zoledronic acid (5 mg) and daily subcutaneous teriparatide (...
    Medical condition: Postmenopausal women with severe osteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed) DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 20:41:53 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA